BSE filing, NSE: FISCHER. Summary written from the filing by ALFA Finder's alert engine.
Fischer Medical Ventures Ltd: key numbers
- Share price
- ₹24.79
- Market cap
- ₹1,717 Cr
- Revenue (annual)
- ₹308.6 Cr
- Net profit (annual)
- ₹31.02 Cr
- P/E (TTM)
- 57.6×Sector 34.1×
- Promoter holding
- 63.08%+0.93% QoQ
- FII holding
- 6.71%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Fischer Medical Ventures Ltd
All →Fischer Medical Ventures Other Announcement
Fischer Medical Ventures Ltd filed its quarterly shareholding pattern under Regulation 31. This routine disclosure presents the company's current ownership structure.
Fischer Medical Ventures Annual General Meeting
Fischer Medical Ventures Ltd has issued a Postal Ballot Notice seeking shareholder approval for creating security on subsidiary assets and promoter share pledges for proposed NCD issuance.
Fischer Medical Ventures Board Meeting Outcome
Fischer Medical Ventures' board approved a postal ballot notice for RPT consent and borrowing limits, and appointed a scrutinizer. No material transaction or financial figure was decided at this meeting.
Fischer Medical Ventures Annual General Meeting
Fischer Medical Ventures Limited conducted its 33rd Annual General Meeting via video conferencing on September 29, 2026, with the requisite quorum present.
Fischer Medical Ventures Other Announcement
Fischer Medical Ventures' subsidiaries declared dividends totaling ₹26.95 Crore. This update provides financial information regarding subsidiary cash flows to the exchange.
- Value
- ₹26.95 Cr
Fischer Medical Ventures Annual Report
The company issued a corrigendum to its FY 2025-26 Annual Report. This update corrects financial highlights, auditor report details, and capital management tables.
Other management change announcements
All →Zydus Lifesciences Management Change
Zydus Lifesciences announced the resignation of Dr. Amrut Naik, President of International Markets, effective 7 November 2026. Mr. Christoph Stoller has been appointed to the same senior management role from 2 November 2026.
Vahh Chemicals Management Change
VAHH Chemicals Limited appointed Ms. Shubhangi Rajesh Gadia as Company Secretary and Compliance Officer, effective 01 November 2026. The appointment was approved at a board meeting held on 31 October 2026.
Capital India Finance Management Change
Capital India Finance reports that Senior Management Personnel Ravindran Menon resigned, ceasing to be associated with the company from close of business on 31 October 2026. The resignation letter is enclosed.
Bank of Maharashtra Management Change
Bank of Maharashtra disclosed that Chief General Manager Dinkar Sankpal ceased to hold the post at close of 31 October 2026 on superannuation. This is a senior management departure.
Seksaria Finance Management Change
Seksaria Finance's Company Secretary and Compliance Officer, Amar Hasmukh Trivedi, resigned effective close of business on 31 October 2026. The board accepted the resignation at its 29 October 2026 meeting.
Nova Iron & Steel Management Change
Nova Iron and Steel appointed Palak Jindal as independent director and re-appointed Hardev Chand Verma as non-executive director. Both changes are board-level management updates.